BioCardia Beheer
Beheer criteriumcontroles 4/4
BioCardia's CEO is Peter Altman, appointed in Jan 2002, has a tenure of 22.83 years. total yearly compensation is $746.24K, comprised of 69.1% salary and 30.9% bonuses, including company stock and options. directly owns 2.97% of the company’s shares, worth $248.51K. The average tenure of the management team and the board of directors is 8.7 years and 8.1 years respectively.
Belangrijke informatie
Peter Altman
Algemeen directeur
US$746.2k
Totale compensatie
Percentage CEO-salaris | 69.1% |
Dienstverband CEO | 22.8yrs |
Eigendom CEO | 3.0% |
Management gemiddelde ambtstermijn | 8.7yrs |
Gemiddelde ambtstermijn bestuur | 8.1yrs |
Recente managementupdates
Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable
May 14Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns
Oct 12Recent updates
Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable
May 14Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns
Oct 12BioCardia stock rises on contract for delivery products for BlueRock's cell therapies
Aug 24Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?
Aug 24Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation
May 10We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully
Jan 06We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully
Sep 23Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$9m |
Mar 31 2024 | n/a | n/a | -US$10m |
Dec 31 2023 | US$746k | US$516k | -US$12m |
Sep 30 2023 | n/a | n/a | -US$13m |
Jun 30 2023 | n/a | n/a | -US$13m |
Mar 31 2023 | n/a | n/a | -US$12m |
Dec 31 2022 | US$902k | US$531k | -US$12m |
Sep 30 2022 | n/a | n/a | -US$12m |
Jun 30 2022 | n/a | n/a | -US$12m |
Mar 31 2022 | n/a | n/a | -US$13m |
Dec 31 2021 | US$1m | US$488k | -US$13m |
Sep 30 2021 | n/a | n/a | -US$12m |
Jun 30 2021 | n/a | n/a | -US$13m |
Mar 31 2021 | n/a | n/a | -US$13m |
Dec 31 2020 | US$883k | US$380k | -US$15m |
Sep 30 2020 | n/a | n/a | -US$16m |
Jun 30 2020 | n/a | n/a | -US$15m |
Mar 31 2020 | n/a | n/a | -US$16m |
Dec 31 2019 | US$747k | US$363k | -US$15m |
Sep 30 2019 | n/a | n/a | -US$15m |
Jun 30 2019 | n/a | n/a | -US$15m |
Mar 31 2019 | n/a | n/a | -US$14m |
Dec 31 2018 | US$1m | US$360k | -US$14m |
Sep 30 2018 | n/a | n/a | -US$14m |
Jun 30 2018 | n/a | n/a | -US$13m |
Mar 31 2018 | n/a | n/a | -US$13m |
Dec 31 2017 | US$372k | US$310k | -US$12m |
Compensatie versus markt: Peter's total compensation ($USD746.24K) is about average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Peter's compensation has been consistent with company performance over the past year.
CEO
Peter Altman (57 yo)
22.8yrs
Tenure
US$746,237
Compensatie
Dr. Peter A. Altman, Ph.D. has been Chief Executive Officer and President of BioCardia, Inc. since 2002. Dr. Altman served as an acting Chief Executive Officer of Lumen Therapeutics from 2004 to 2005. He s...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, President & Director | 22.8yrs | US$746.24k | 2.97% $ 248.5k | |
Chief Financial Officer | 8.7yrs | US$469.47k | 0.86% $ 71.7k | |
Senior Vice President of Devices | 4.1yrs | US$326.37k | 0.35% $ 29.2k |
8.7yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren management: BCDA's management team is seasoned and experienced (8.7 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, President & Director | 22.8yrs | US$746.24k | 2.97% $ 248.5k | |
Independent Director | 13.8yrs | US$65.29k | 0.10% $ 8.6k | |
Independent Director | 8.1yrs | US$57.79k | 0.090% $ 7.5k | |
Independent Director | 1.1yrs | US$24.69k | geen gegevens | |
Independent Director | 22.8yrs | US$47.55k | 2.84% $ 237.4k | |
Independent Director | 5.1yrs | US$49.29k | 3.13% $ 262.1k | |
Independent Chairman | 5.1yrs | US$97.79k | 4.13% $ 345.4k |
8.1yrs
Gemiddelde duur
68yo
Gemiddelde leeftijd
Ervaren bestuur: BCDA's board of directors are considered experienced (8.1 years average tenure).